Eva Morava-Kozicz, MD, PhD, M.D

Rare Disease / Clinical Research

Icahn School of Medicine at Mount Sinai

ROCHESTER, MN

PI on 7 trialsNPI: 1376899203

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

SRD5A3-CDG
SLC39A8-CDG
ALG1-CDG
SSR4-CDG
Disorder of galactose metabolism
SLC35A2-CDG
PGM1-CDG
PMM2-CDG
Alacrimia-choreoathetosis-liver dysfunction syndrome
MAN1B1-CDG
ALG3-CDG
ALG12-CDG
ALG6-CDG
MPDU1-CDG
ALG13-CDG
DPAGT1-CDG
DPM1-CDG
MPI-CDG
Congenital disorder of glycosylation
ALG2-CDG

Clinical trials (7)

NCT05402345
NCT02955264
NCT04199000
NCT04925960
NCT05402332
NCT05402384
NCT04679389

Verify independently

ClinicalTrials.gov PI search for Eva Morava-Kozicz, MD, PhD
NPPES NPI registry entry

Other specialists for SRD5A3-CDG

Peers ranked by clinical-trial PI role, publications, and verification quality.

Betul Emine Derinkuyu, MD
University of Health Sciences
OH
Merve Yoldas Celik
Ege University Faculty of Medicine
Havva Yazici
Ege University Faculty of Medicine
Asburce Olgac
University of Health Sciences
Ulkuhan Oztoprak
University of Health Sciences
Melissa Rieger, D.C
Institute of Human Genetics
MO
Mandy Krumbiegel
Institute of Human Genetics
Sayyed Hesamedin Nabavizadeh
School of Medicine Shiraz University of Medical Sciences Shiraz Iran.

See all specialists for SRD5A3-CDG →

← Back to specialists directory